Webinar: CKD in clinical practice: Strategies for Early Intervention
Sponsored by a hands-off grant from Boehringer-Ingelheim. They have had no input into the session content or agenda.
Webinar Details
Sponsored by a hands-off grant from Boehringer-Ingelheim. They have had no input into the session content or agenda.
WEBINAR: CKD in clinical practice: Strategies for Early Intervention
Date and time: Thursday 3rd July 2025 at 1pm - 2pm
Three key takeaways
1. Understand the classification of ckd into low, moderate, high and very high risk cohorts
2. Understand the importance of managing CV risks in people with CKD, including the role of RAAS and SGLT2i
3. Understand the sick day rules in CKD
Speaker:
Helen Williams, National Clinical Director for CVD Prevention, NHSE -Consultant Pharmacist and PCPA Cardiovascular Specialist Pharmacy Lead
Chair:
Robin Conibere, Lead PCN Pharmacist, Partner & PCPA Regional Vice President
Speaker
Helen Williams,
As Consultant Pharmacist for CVD Disease, Helen is involved in a wide range of activities across South London to improve the care of patients with or at risk of cardiovascular disease (CVD). Helen chairs the local cardiovascular medicines working group which develops and supports the implementation of consensus evidence-based guidance for use across South London’s 12 clinical commissioning groups and 7 acute trusts, covering a population of 3.6million.
In addition, Helen is an editorial board member for the British Journal of Cardiology and the Journal of Medicines Optimisation and works with NICE on the development of a number of cardiovascular guidelines.
